There’s no doubt that the cost of insulin is increasing. According to the Health Care Cost Institute, between the years 2012 and 2016 gross spending on the prescription drug rose by $2,841 per person. Now one state is doing something to lower the often-hefty price tag that comes with a type 1 diabetes diagnosis. And it just might save lives!

Colorado recently became the first state to put a price cap on private insurance copays for insulin. While it’s not unheard of (actually, it’s pretty common) for a diabetic to pay hundreds of dollars a month to get this life-saving medication, Colorado’s new legislation puts a $100 per month limit on out-of-pocket spending.

According to CBS Denver, Governor Jared Polis (who signed the bill into law) said, “We declare that the days of insulin price gouging are over in Colorado.” Even though the law won’t regulate how much drug manufacturers charge for insulin, it will directly keep costs down for patients.

If you’re wondering just how widespread or serious this issue is, take a look at use stats. According to Yale researchers, more than one-quarter of diabetics report using less insulin than needed due to the prohibitively costly price tag.

While it doesn’t look like the cost of insulin will decrease anytime soon, legislation like Colorado’s can help diabetics to get the life-saving medication they need—without having to go into debt to foot the bill.

—Erica Loop

Featured photo: Stevepb via Pixabay

 

RELATED STORIES

What State Will Require Warning Labels on Sugary Drinks Soon?

New Study Proves Why It’s Important to Always Focus on the Positive

Science May Have Found a Way to Treat Down Syndrome Before Birth